SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-054142
Filing Date
2014-02-14
Accepted
2014-02-14 14:05:00
Documents
1
Group Members
JAMES NIEDELJEANI DELAGARDELLELIAM RATCLIFFENEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.PHILIPPE O. CHAMBONRONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G d675819dsc13g.htm SC 13G 163507
  Complete submission text file 0001193125-14-054142.txt   165383
Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

IRS No.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Subject) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87926 | Film No.: 14614478
SIC: 2835 In Vitro & In Vivo Diagnostic Substances